A dealership then told him it would cost $1,600 to diagnose and repair. Asher Koreman said he bought his 2021 Volkswagen ...

If you're looking to pick up a new key fob, or repair one, you might wonder how long programming it takes and whether or not ...

Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...

Add Yahoo as a preferred source to see more of our stories on Google. Modern glaucoma treatments can only preserve a patient's current level of vision, offering no hope of restoration. A new Phase 1 ...

Brian Dakss is a longtime New York-based editor and writer for CBS News, at the Radio network and with CBSNews.com. He has written and edited for NBC News, Dow Jones and numerous radio stations and ...

Chrysler is ready for a rebirth, says Ralph Gilles, Stellantis global design chief and the man who must sign off on the look for that renaissance. The brand is ripe for reinvestment and will use the ...

The car—seemingly the Chrysler-specific Airflow crossover—appears briefly in a YouTube video providing an overview of Stellantis powertrains. Thanks to a heavy focus on sharp angles, it shares some of ...

It’s getting hard to think of a modern car with as convoluted a history as the upcoming Chrysler Airflow, and it isn’t even out yet. The saga has taken its latest twist thanks to a video published by ...

At Stellantis' investor day in Auburn Hills, the company announced Chrylser and Dodge will be launching new vehicles. New vehicles with the Chrysler badge is big news for a previously iconic brand ...

Stellantis has used their Investor Day to announce plans to quadruple Chrysler’s lineup. As part of the effort, the Pacifica will be joined by three new crossovers by 2030. The company isn’t saying ...

Alina has been enthusiastic about vehicles her entire life, and even from an early age found herself itching to get behind the wheel. Through high school and college, she could be found reading ...

Actimab-A combinations enhanced in vivo AML cell killing across multiple preclinical models, independent of mutation status, when combined with standard-of-care targeted and non-targeted therapies ...